You are here

Theravance

Theravance reintroduces Vibativ to the U.S. market

The Fly on the Wall

Wed, 08/14/13 - 11:21 am

hospital-acquired bacterial pneumonia

Respiratory Drug Maker About to Take Off

Motley Fool

Sun, 08/4/13 - 11:25 am

Theravance announces FDA Advisory Committee to review Anoro Ellipta

Yahoo/Fly on the Wall

Fri, 08/2/13 - 10:56 am

advisory panels

Theravance Narrows Loss

Yahoo/Zacks

Sat, 07/27/13 - 11:10 am

3 Potential Game Changers for COPD

Motley Fool

Wed, 07/17/13 - 10:59 am

Boehringer Ingelheim

GSK, Theravance pull Relvar filing for COPD in Japan

Reuters

Fri, 07/12/13 - 10:49 am

Theravance, GlaxoSmithKline: Breo Ellipta approved for COPD treatment in Canada

Yahoo/Fly on the Wall

Wed, 07/10/13 - 10:26 am

Are You Valuing This Biotechnology Company Correctly?

Motley Fool

Sun, 06/30/13 - 10:43 am

Theravance Announces FDA Approval of VIBATIV(R) (telavancin) for the Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

Yahoo/Market Wired

Sat, 06/22/13 - 10:25 am

hospital-acquired bacterial pneumonia

Elan CEO Says Alternatives Exist If Shareholders Reject Deals

Bloomberg

Thu, 05/30/13 - 11:41 am

Theravance Looks to Reward Shareholders by Splitting Into Two Distinct Companies

Motley Fool

Thu, 05/16/13 - 09:01 am

Did Elan Just Overpay On Theravance To Spurn Its Hostile Suitor?

Forbes

Mon, 05/13/13 - 11:32 am

Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales

Yahoo/AP

Mon, 05/13/13 - 09:36 am

This Week in Biotech

Motley Fool

Sun, 05/12/13 - 11:02 am

Pain Therapeutics

Breo Ellipta gains US approval for the treatment of COPD

Yahoo/PR Newswire

Sat, 05/11/13 - 11:20 am

FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease

Yahoo/Fly on the Wall

Fri, 05/10/13 - 12:31 pm

3 Biotech Companies Ripe for a Takeover

Motley Fool

Tue, 04/30/13 - 09:00 am

Arena Pharmaceuticals

This Week in Biotech

Motley Fool

Sun, 04/28/13 - 12:13 pm

Gilead Sciences

Theravance to Split After Ending Review of Alternatives

Bloomberg

Sat, 04/27/13 - 09:55 am

Theravance to split into two listed companies

Reuters

Fri, 04/26/13 - 11:04 am

Pages